High Septal Pacing for Cardiac Resynchronization Therapy Acute Research Study

Boston Scientific Corporation1 site in 1 country15 target enrollmentAugust 2011

ConditionsHeart Failure Left Bundle Branch Block Heart Disease

Overview

Phase: N/A
Intervention: Not specified
Conditions: Heart Failure
Sponsor: Boston Scientific Corporation
Enrollment: 15
Locations: 1
Status: Terminated
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this acute study is to perform a preliminary investigation of high septal right ventricular pacing in the vicinity of the His bundle region as an alternate or adjunctive means for cardiac resynchronization in patients with heart failure and wide QRS.

Detailed Description

The HISTORY Study is an acute, cross-sectional, multi-center, feasibility study with a randomized within patient test sequence designed to characterize the effects of high septal right ventricular pacing in the vicinity of the His bundle region compared to conventional biventricular pacing for cardiac resynchronization therapy.

Registry

clinicaltrials.gov

Start Date

August 2011

End Date

May 2012

Last Updated

13 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Boston Scientific Corporation

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•50 years of age or older
•Patients willing and capable of providing informed consent, participating in all testing associated with this clinical investigation
•Patients undergoing a CRT implant procedure (pacemaker or defibrillator) for one of the following reasons
•Indicated for a new device
•Device upgrade
•Device replacement
•Lead revision
•Note: recognized indications for CRT-P and CRT-D as of October 2009 are valid for inclusion in this study. Should new indications become approved during the study conduct; those will also be applied within the inclusion criteria.

Exclusion Criteria

•Patients unwilling or incapable of signing the informed consent, or patients having previously withdrawn their consent
•Patients in AF that cannot be cardioverted for the study
•RBBB pattern
•Sustained, uncontrolled ventricular tachycardia
•Sinus rhythm \< 30 bpm or \>100 bpm
•Complete AV node block
•Second degree AV block
•Women who are pregnant or plan to become pregnant during the study (method of assessment upon physician's discretion);
•History of (hemorrhagic) cerebro-vascular accident or TIA